Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women
暂无分享,去创建一个
Karen C Johnson | R. Chlebowski | M. Neuhouser | L. Qi | J. Wactawski‐Wende | K. Johnson | S. Beresford | T. Cheng | Xiaoling Song | G. Ho | M. Datta | K. Johnson
[1] Mary E Reid,et al. The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] J. Manson,et al. Update on the Vitamin D and OmegA-3 trial (VITAL) , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[3] H. Brenner,et al. Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium , 2016, European Journal of Epidemiology.
[4] Ling Wang,et al. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis , 2015, Cancer Causes & Control.
[5] A. LaCroix,et al. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers , 2014, International journal of cancer.
[6] Jennifer G. Robinson,et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial , 2014, Menopause.
[7] G. Hankey,et al. In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer , 2014, PloS one.
[8] A. LaCroix,et al. Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. , 2014, The Journal of nutrition.
[9] T. Jørgensen,et al. Prospective Population-Based Study of the Association between Serum 25-Hydroxyvitamin-D Levels and the Incidence of Specific Types of Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[10] S. Novello,et al. Lung cancer in never smokers: a different disease , 2014, Current Respiratory Care Reports.
[11] J. Witte,et al. Antioxidant and vitamin E transport genes and risk of high‐grade prostate cancer and prostate cancer recurrence , 2013, The Prostate.
[12] A. LaCroix,et al. Vitamin D intake and lung cancer risk in the Women's Health Initiative. , 2013, The American journal of clinical nutrition.
[13] Q. Hu,et al. Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[14] S. Bojesen,et al. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. , 2013, Clinical chemistry.
[15] H. Brenner,et al. Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[16] M. Neuhouser,et al. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient–nutrient interaction , 2012, Cancer Causes & Control.
[17] A. Muñoz,et al. Vitamin D and colon cancer. , 2012, Endocrine-related cancer.
[18] R. Genco,et al. Intraindividual Variation in Plasma 25-Hydroxyvitamin D Measures 5 Years Apart among Postmenopausal Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[19] A. LaCroix,et al. The Effect of Calcium plus Vitamin D on Risk for Invasive Cancer: Results of the Women's Health Initiative (WHI) Calcium Plus Vitamin D Randomized Clinical Trial , 2011, Nutrition and cancer.
[20] Kai Yu,et al. Serum 25-Hydroxyvitamin D and Risk of Lung Cancer in Male Smokers: A Nested Case-Control Study , 2011, PloS one.
[21] T. Rohan,et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study , 2011, BMJ : British Medical Journal.
[22] Christine L. Taylor,et al. Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.
[23] C. Abnet,et al. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). , 2010, Cancer research.
[24] C. Abnet,et al. Serum Vitamin D and Cancer Mortality in the NHANES III Study (1988–2006) , 2010 .
[25] Erika Avila-Tang,et al. Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors , 2009, Clinical Cancer Research.
[26] M. Thun,et al. Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. , 2009, American journal of epidemiology.
[27] S. Bondy,et al. Origin and use of the 100 cigarette criterion in tobacco surveys , 2009, Tobacco Control.
[28] G. Hunninghake,et al. Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense1 , 2008, The Journal of Immunology.
[29] A. Aromaa,et al. Vitamin D Status and the Risk of Lung Cancer: A Cohort Study in Finland , 2008, Cancer Epidemiology Biomarkers & Prevention.
[30] S. Lippman,et al. Lung cancer. , 2008, The New England journal of medicine.
[31] R. Salgia,et al. Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue , 2008, Cancer Epidemiology Biomarkers & Prevention.
[32] E. Giovannucci. Can vitamin D reduce total mortality? , 2007, Archives of internal medicine.
[33] D. Trump,et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.
[34] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[35] W. Willett,et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.
[36] Yan Liu,et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.
[37] J. Manson,et al. Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.
[38] John Robbins,et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.
[39] U. Kaiser,et al. Expression of vitamin D receptor in lung cancer , 2005, Journal of Cancer Research and Clinical Oncology.
[40] Garnet L Anderson,et al. The Women's Health Initiative recruitment methods and results. , 2003, Annals of epidemiology.
[41] C. Kooperberg,et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.
[42] D. Galuska,et al. High Serum Retinyl Esters Are Not Associated with Reduced Bone Mineral Density in the Third National Health and Nutrition Examination Survey, 1988–1994 , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] A. Kristal,et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.
[44] A. Kristal,et al. Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative , 1999, Public Health Nutrition.
[45] H. Cross,et al. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. , 1999, Oncology research.
[46] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[47] S. Greenland,et al. Simulation study of confounder-selection strategies. , 1993, American journal of epidemiology.
[48] C. Carlberg,et al. Two nuclear signalling pathways for vitamin D , 1993, Nature.
[49] R. Russell,et al. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. , 1989, The American journal of clinical nutrition.